These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus. Alawadi F, Alsaeed M, Bachet F, Bashier A, Abdulla K, Abuelkheir S, Rashid F, Abdulaziz Bin Hussain A, Abdelgadir E, Alsayyah F, Elsayed M, Hassanein M. Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155 [Abstract] [Full Text] [Related]
6. Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study. Hassanein M, Malek R, Shaltout I, Sahay RK, Buyukbese MA, Djaballah K, Pilorget V, Coudert M, Al Sifri S, SoliRam Study Investigators. Diabetes Metab Syndr; 2023 Feb; 17(2):102707. PubMed ID: 36680967 [Abstract] [Full Text] [Related]
7. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. Afandi B, Kaplan W, Al Hassani N, Hadi S, Mohamed A. J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763 [Abstract] [Full Text] [Related]
12. Impact of Ramadan Focused Education Program on medications adjustment for patients with type 2 diabetes in a primary health care institution in Saudi Arabia. Tourkmani AM, Alharbi TJ, Bin Rsheed AM, AlRasheed AN, AlBattal SM, Abdelhay O, Hassali MA, Faya SI, Assiri ES, Al Ghishiayan KI, Alrasheedy AA, Abbas MA. Diabetes Metab Syndr; 2019 Aug; 13(1):161-165. PubMed ID: 30641690 [Abstract] [Full Text] [Related]
17. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study. Khalil AB, Beshyah SA, Abu Awad SM, Benbarka MM, Haddad M, Al-Hassan D, Kahwatih M, Nagelkerke N. Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507 [Abstract] [Full Text] [Related]
18. Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study. Hassanein M, El Naggar A, Al Sheikh A, Djaballah K, Saeed M, Melas-Melt L, AlSifri S. Diabetes Res Clin Pract; 2024 Mar; 209():111567. PubMed ID: 38341039 [Abstract] [Full Text] [Related]
19. The effect of Ramadan fasting on glycaemic control in insulin dependent diabetic patients: A literature review. Alabbood MH, Ho KW, Simons MR. Diabetes Metab Syndr; 2017 Mar; 11(1):83-87. PubMed ID: 27402028 [Abstract] [Full Text] [Related]
20. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study. Hassanein M, Abdallah K, Schweizer A. Vasc Health Risk Manag; 2014 Mar; 10():319-26. PubMed ID: 24920915 [Abstract] [Full Text] [Related] Page: [Next] [New Search]